This page explains the mood-related side effects of atomoxetine (Strattera) using current FDA-approved prescribing information. It focuses on how this ADHD medication may affect mood, anxiety, and emotional regulation. This summary does not replace the official label. Always review full prescribing information and speak with your healthcare provider.
Founder at Anticipate
Updated:
Anticipate is not a medical provider and does not offer medical advice, diagnosis or treatment. The content on this page is informational and should not replace advice from your healthcare professional. Always speak with your clinician about medication questions or changes in mood.
Primary source: FDA Prescribing Information – Atomoxetine (Strattera) – Latest revision via DailyMed
Atomoxetine (brand name Strattera) is a non-stimulant ADHD medication approved by the FDA for children, adolescents, and adults.
Unlike stimulant medications, Strattera works by increasing levels of norepinephrine in the brain. This chemical affects attention, alertness, and emotional control.
Because norepinephrine also influences stress and mood, the effects of atomoxetine may include emotional changes.
Understanding how Strattera works helps explain its side effects. Atomoxetine blocks the reuptake of norepinephrine. This increases its activity in the brain. Norepinephrine plays a role in:
For many people, this improves ADHD symptoms. For others, it may temporarily increase anxiety, irritability, or restlessness.
Source: FDA Label – Section 12 Clinical Pharmacology (Strattera)
According to FDA prescribing information, common side effects may include:
These common side effects are more likely:
Some people ask about taking Strattera at night. While many take it in the morning, others may use split doses depending on their prescription. If insomnia or sleep disruption occurs, clinicians may adjust the timing of the dose. Any changes to dosing or timing should only be made under medical supervision.
The FDA label also describes potential serious side effects, including:
This medication carries an FDA boxed warning for increased risk of suicidal ideation in young patients. Immediate medical attention is required if severe behavioral changes occur.
Yes, atomoxetine can affect mood. Because it changes norepinephrine activity, some people experience:
Others report improved emotional control over time. Effects vary by person and by dose of atomoxetine. Monitoring mood during early treatment is recommended.
Mood effects may depend on:
If mood symptoms worsen after a dose adjustment, speak with your clinician. Never change your dose without medical advice.
Atomoxetine can interact with other medications. Important drug interactions include:
Always inform your clinician about all medications and supplements.
Precautions include:
Always discuss medical history before starting the medication.
The FDA recommends monitoring for behavioral and emotional changes, especially:
Structured mood tracking can make patterns easier to detect and discuss with a healthcare provider.
Anticipate is not a medical device and does not replace professional care. However, as a privacy-focused mood tracking app, it can support structured awareness during atomoxetine treatment.
It can help users monitor:
Over time, this structured health tracking may help individuals prepare for therapy or medication follow-ups with clearer observations.
For UK users, official prescribing and safety information is available via:
These sources similarly list irritability, mood changes, anxiety, and sleep disturbance as possible adverse reactions.
This page is based on publicly available regulatory sources including:
Information is reviewed periodically to reflect current official updates.
Scan to download
Scan to download
